Skip to main content

Table 4 Predictors of sexual dysfunction after surgery – univariate logistic regression analysis

From: Efficacy comparison of optimal natural orifice specimen extraction for robotic middle rectal cancer resection in women: transanal or transvaginal orifice

Variable

Normal (n=42)

Dysfunction (n=21)

OR (95% CI)

P

Surgery Procedure, n (%)

    

RATV group

18(42.9)

11(52.4)

1.777(0.5006-6.237)

0.369

RATA group

24(57.1)

10(47.6)

1 (ref)

 

Age at surgery, n (%), years

    

≤50

14(33.3)

11(52.4)

1 (ref)

 

>50

28(66.7)

10(47.6)

0.764(0.093-6.280)

0.803

Menopausal status, n (%)

    

Pre-

18(42.9)

15(71.4)

1 (ref)

 

Post-

24(57.1)

6(28.6)

0.813(0.102-6.510)

0.846

BMI, median (IQR), kg/m2

22.7(20.7-24.9)

23.2(20.1-25.1)

0.980(0.791-1.215)

0.855

Tumour diameter, n (%), cm

    

≤2

15(35.7)

4(19.0)

1 (ref)

 

>2

27(64.3)

17(81.0)

3.443(0.674-17.596)

0.137

Pathological TNM stage, n (%)

    

I

15(35.7)

4(19.0)

1 (ref)

 

II

5(11.9)

6(28.6)

3.845(0.494-29.920)

0.198

III

22(52.4)

11(52.4)

0.428(0.049-3.750)

0.443

Histological differentiation, n (%)

    

Well

16(38.1)

4(19.1)

1 (ref)

 

Moderate

20(47.6)

15(71.4)

3.428(0.405-29.002)

0.258

Poor

6(14.3)

2(9.5)

6.137(0.405-92.963)

0.191

  1. Values are presented as mean ± SD, median and IQR (interquartile range), or n (%)
  2. BMI, body mass index; RATV, robotic-assisted transvaginal specimen extraction surgery; RATA, robotic-assisted transanal specimen extraction surgery